Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.49 |
| ▸ | PSEN1 | P49768 | 7/20 | 0.47 |
| ▸ | PSEN2 | P49810 | 7/20 | 0.47 |
| ▸ | APH1B | Q8WW43 | 7/20 | 0.47 |
| ▸ | NCSTN | Q92542 | 7/20 | 0.47 |
| ▸ | APH1A | Q96BI3 | 7/20 | 0.47 |
| ▸ | PSENEN | Q9NZ42 | 7/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.46 |
| ▸ | CNR2 | P34972 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2872778 | 0.89 | PSEN1 (0.43) | SCARB1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL350674 | 0.85 | PSEN1 (0.52) | SCARB1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4725248 | 0.81 | SCARB1 (0.52) | SCARB1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4155967 | 0.81 | MAPT (0.59) | SCARB1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4727503 | 0.80 | SCARB1 (0.53) | SCARB1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4151119 | 0.80 | PSEN1 (0.47) | SCARB1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL2875400 | 0.79 | PSEN1 (0.53) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL19559314 | 0.78 | MAPT (0.61) | SCARB1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL4729148 | 0.76 | SCARB1 (0.47) | SCARB1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL3932512 | 0.76 | CNR2 (0.59) | SCARB1PSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8420231-B2 | Iridium phosphorescent dendrimer, method of preparing the same and electroluminescent device including the iridium phosphorescent dendrimer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-16 | — | — | US | disclosed |
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | SAMSUNG ELECTRONICS CO., LTD (KR) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | DNM1, FIS1, DCUN1D1 | SCARB1 3453/4885PSEN1 3218/4885PSEN2 4384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.